NCT07086482

Brief Summary

The goal of this clinical trial is to learn if the use of cyanoacrylate glue (PeriAcryl) is effective in healing of the palatal donor site in adults requiring a free gingival graft. The main question\[s\] it aims to answer \[is/are\]: Does PeriAcryl accelerate the palatal tissue healing compared with the use of collagen sponge? Does PeriAcryl usage leave the patients more satisfied? Researcher will compare the outcomes of participants treated with PeriAcryl to those treated with collagen sponge to see if PeriAcryl accelerated the healing process of palatal tissues and led to fewer postoperative complications. Participants will:

  • be assigned to a study group using PeriAcryl or control group using Collagen sponge.
  • be followed-up to monitor healing and gather clinical information.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
22

participants targeted

Target at P25-P50 for early_phase_1

Timeline
Completed

Started Aug 2025

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 25, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

August 4, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2026

Completed
Last Updated

August 17, 2025

Status Verified

August 1, 2025

Enrollment Period

8 months

First QC Date

July 18, 2025

Last Update Submit

August 13, 2025

Conditions

Keywords

palatal donor areaCyanoacrylate gluewound healingfree gingival graft

Outcome Measures

Primary Outcomes (3)

  • Healing of palatal wound

    Healing will be evaluated using Laundry Wound Healing Index (WHI). WHI has a score range of 1 (very poor) to 5 (excellent), evaluates tissue color, response to palpation, presence of granulation tissue, epithelialization of incision margins, and amount of suppuration.

    1 month, 2 months and 3 months post-operatively.

  • Epithelization of the palatal wound

    The complete epithelialization will be evaluated clinically by applying 3% hydrogen peroxide into the palatal wound. If bubble formation is not observed, epithelization will be recorded as complete, whereas if bubbles are observed, epithelization will be recorded as incomplete.

    On every follow-up session: 7 days, 14 days, 21 days, 1 month, 2 months and 3 months post-operatively.

  • Color Match

    Tissue color match (CM) will be assessed with adjacent and contralateral palatal tissue (0-no color matching to 10-excellent color matching).

    3 months post-operatively

Secondary Outcomes (6)

  • Post-operative Pain

    Every day for 7 days, and on the 14th day.

  • Inflammation Degree

    Every day for 7 days, and on the 14th day.

  • Post-operative Bleeding

    Every day for 7 days, and on the 14th day.

  • Presence of Hyperesthesia

    Every day for 7 days, and on the 14th day.

  • Number of Analgesic Pills Taken

    During the first 14 days post-operatively.

  • +1 more secondary outcomes

Study Arms (2)

Collagen sponge

ACTIVE COMPARATOR

Participants will be treated with collagen sponge at the palatal donor wound to achieve hemostasis. After FGG harvest, pressure will be applied at the palatal wound using a gauze soaked in saline to top the bleeding, then a collagen sponge will be placed and stabilized with 4/0 silk (x) sutures.

Device: Collagen sponge

Cyanoacrylate tissue adhesive

EXPERIMENTAL

Participants will be treated with cyanoacrylate tissue adhesive (PeriAcryl) at the palatal donor wound to achieve hemostasis. After FGG harvest, pressure will be applied at the palatal wound using a gauze soaked in saline to top the bleeding, then PeriAcryl will be applied with a pipette following manufacturer's instructions on the entire area of the wound.

Combination Product: Cyanoacrylate tissue adhesive

Interventions

Cyanoacrylate tissue adhesive is a chemical synthetic and hybrid tissue sealant possessing strong, rapid acting adhesive properties and is often used in general surgery. Recently, cyanoacrylate tissue adhesive has been effectively introduced into dentistry to close wounds and stop ischemic areas from forming in periodontal aesthetic surgeries. As well as in exposed membranes to preserve the bone graft after guided bone regeneration, in post-extraction sockets, and to seal any surgical flap. This material has strong hemostatic, bacteriostatic, and sealing qualities.

Also known as: PeriAcryl
Cyanoacrylate tissue adhesive

Collagen sponge is an organic polymer that promotes the development of blood clots, and it resorbs quickly and completely over time. Collagen sponge create a matrix at the bleeding site, encourage platelet activation and aggregation, and engage the extrinsic coagulation pathway. Thus, it can be utilized as the first choice for wound healing.

Collagen sponge

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Low-moderate anesthetic risk (ASA I-II)
  • No restriction on ethnicity or gender
  • Patients requiring FGG from the palate for periodontal plastic surgery
  • Clinically healthy gingiva after phase I therapy
  • Full-mouth plaque index grades 0 and 1
  • Bleeding scores \<15%

You may not qualify if:

  • Patients who smoke \> 10 cigarettes/day
  • Patients with coagulation disorders
  • Systemic diseases
  • Patients on certain medications that may affect periodontal tissues
  • Pregnant and lactating patient
  • Patients with allergies to drugs that will be prescribed during the treatment phase
  • Pathological mental conditions (dementia, psychosis) and lack of cooperation
  • Excessive gag reflex

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beirut Arab University

Beirut, Lebanon

RECRUITING

MeSH Terms

Conditions

Wounds and Injuries

Study Officials

  • Nayer Aboelsaad

    Professor

    STUDY CHAIR

Central Study Contacts

Dania EL Rostom, MSc Oral and Dental Surgery

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2025

First Posted

July 25, 2025

Study Start

August 4, 2025

Primary Completion

March 20, 2026

Study Completion

April 20, 2026

Last Updated

August 17, 2025

Record last verified: 2025-08

Locations